期刊文献+

百令胶囊对慢性肾功能衰竭微炎症状态患者IL-6、CRP的影响 被引量:7

Effect of Bailing Capsule on IL-6 and CRP in Patients with CRF Micro Inflammation Status
下载PDF
导出
摘要 目的观察百令胶囊对慢性肾功能衰竭(chronic renal failure,CRF)微炎症状态患者血清IL-6、CRP含量的影响。方法2012年6月至2013年8月便利抽样选取济南军区青岛第一疗养院门诊和住院CRF患者50例,采用随机数字表法分为治疗组25例,对照组25例。两组均予常规治疗,治疗组同时服用百令胶囊,每日3次,每次6粒,每疗程1个月,观察3个疗程。比较治疗前后患者血清IL-6、CRP含量的变化。结果治疗前后同组比较,两组患者IL-6、CRP含量均显著降低(均P<0.01);治疗后与对照组相比,治疗组IL-6、CRP含量显著降低(均P<0.01)。结论百令胶囊能有效改善CRF患者微炎症状态,这可能与下调IL-6、CRP水平相关。 Objective To observe the effect of bailing capsule on IL-6 and CRP in patients with CRF micro inflammation status.Methods By convenience sampling,50 cases of patients with CRF were selected and divided into treatment group(25) and control group(25).Both groups had conventional treatment, while the treatment group at the same time took the Bailing capsule, 3 times per day, 6 pills a time for one month with 3 months observation.The serum IL-6 and the change of CRP levels before and after treatment were compared.Results Compared with before treatment,the treatment group and control group IL-6,CRP con- tent were significantly decreased after treatment (all P 〈0.01);Compared with the control group after treatment, the treatment group IL-6, CRP content significantly decreased after treatment (all P 〈 0.01 ). Conclusion Bailing capsule can effectively improve micro inflammation in patients with CRF;it may be as- sociated with decreased IL-6,CRP levels.
出处 《解放军护理杂志》 CSCD 2014年第13期67-68,共2页 Nursing Journal of Chinese People's Liberation Army
关键词 百令胶囊 慢性肾功能衰竭 微炎症状态 IL-6 CRP Baling capsule CRF micro inflammation status IL-6, CRP
  • 相关文献

参考文献3

二级参考文献53

  • 1南征.毒损肾络所致消渴肾病机理浅说[J].吉林中医药,2007,27(1):8-10. 被引量:44
  • 2许筱颖,郭霞珍.浊毒致病理论初探[J].辽宁中医杂志,2007,34(1):28-29. 被引量:97
  • 3杨彦.肾小管间质纤维化的中医病机探讨[J].江苏中医药,2007,39(5):12-13. 被引量:5
  • 4[1]Locatelli F, Manzoni C, Di Filippo S.The importance of convective transport[J]. Kidney Int Suppl,2002,80:115~20.
  • 5[2]Zimmermann J, Herrlinger S, Pruy A,et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients[J]. Kidney Int,1999,55(2):648~658.
  • 6[3]Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease[J]. Am J Kidney Dis,1998,32:112~119.
  • 7[4]Camici M.C-reactive protein atherosclerosis and cardiovascular disease. An update[J]. Minerva Cardioangiol ,2002,50(4):327~331.
  • 8[5]Arici M,Walls J.End-stage renal disease,atherosclerosis,and cardiovascular mortality:is C-reactive protein the missing link?[J].Kidney Int,2001,59(2):407~414.
  • 9[6]Deppisch RM,Beck W,Goehl H.Complement components as uremic toxins and their potential role as mediators of microinflammation[J].Kidney Int Suppl,2001,78:271~277.
  • 10[7]Sezer S,Ozdemir FN,Arat Z,et al.Triad of malnutrition,inflammation,and atherosclerosis in hemodialysis patients[J].Nephron, 2002,91(3):456~462.

共引文献31

同被引文献96

引证文献7

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部